American College of Gastroenterology
Based in VA
AI Overview
With $1.4M in lobbying spend across 30 quarterly filings, American College of Gastroenterology is a significant lobbying presence. Their lobbying covers 4 issue areas. Active from 2018 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $150K |
| 2019 | $250K |
| 2020 | $200K |
| 2021 | $190K |
| 2022 | $130K |
| 2023 | $180K |
| 2024 | $130K |
| 2025 | $180K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Health Issues, Small Business, Budget/Appropriations
The Patient Protection and Affordable Care Act, Pub. L. 111-148, Section 4104; Colon cancer screening policies in Medicare; Medicare physician quality incentives; Advancement of physician quality registries as they relate to Medicare physician payment reform; Transparency in valuation of medical procedures under Medicare; Issues related to the Medicare physician fee schedule and payment policies for GI services; Proposed changes to Stark Law on self-referral and anti-kickback statute; Public Law 114-10 - The Medicare Access and CHIP Reauthorization Act of 2015 - implementation of payment model and reporting requirements, impact on physicians and QCDRs; physician burden reduction under Medicare, in general; H.R. 3726, Stark Administrative Simplification Act; H.R. 3120, to amend Title XVIII of the Social Security Act to reduce the value of future electronic health record-related significant hardship requests; Pub. Law 115-123, Section 51003, regarding technical amendments to Pub. Law 114-10.
Issues regarding Medical Liability Reform under H.R.1565, Saving Lives, Saving Costs Act.
Issues regarding Medical Liability Reform under H.R.1565, Saving Lives, Saving Costs Act; H.R.2077, Restoring the Patients Voice Act of 2017.
Restoring Patients Voice Act (115th Cong.)
The Patient Protection and Affordable Care Act, Pub. L. 111-148, Section 4104; Colon cancer screening policies in Medicare; Medicare physician quality incentives; Advancement of physician quality registries as they relate to Medicare physician payment reform; Transparency in valuation of medical procedures under Medicare; Issues related to the Medicare physician fee schedule and payment policies for GI services; Proposed changes to Stark Law on self-referral and anti-kickback statute; Public Law 114-10 - The Medicare Access and CHIP Reauthorization Act of 2015 - implementation of payment model and reporting requirements, impact on physicians and QCDRs; physician burden reduction under Medicare, in general; Pub. Law 115-123, Section 51003, regarding technical amendments to Pub. Law 114-10; H.R. 1570/S. 668, The Removing Barriers to Colorectal Cancer Screening Act of 2019.
The Safe Step Act, H.R. 2279; Surprise Billing Legislation, in general; Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019, S. 1531; Protecting People From Surprise Medical Bills Act, H.R. 3502; No Surprises Act, H.R. 3630; Lower Health Care Costs Act, S.1895.
The Patient Protection and Affordable Care Act, Pub. L. 111-148, Section 4104; Colon cancer screening policies in Medicare; Medicare physician quality incentives; Advancement of physician quality registries as they relate to Medicare physician payment reform; Transparency in valuation of medical procedures under Medicare; Issues related to the Medicare physician fee schedule and payment policies for GI services; Proposed changes to Stark Law on self-referral and anti-kickback statute; Public Law 114-10 - The Medicare Access and CHIP Reauthorization Act of 2015 - implementation of payment model and reporting requirements, impact on physicians and QCDRs; physician burden reduction under Medicare, in general; Pub. Law 115-123, Section 51003, regarding technical amendments to Pub. Law 114-10; H.R. 1570/S. 668, The Removing Barriers to Colorectal Cancer Screening Act of 2019; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.
The Safe Step Act, H.R. 2279; Surprise Billing Legislation, in general; Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019, S. 1531; Protecting People From Surprise Medical Bills Act, H.R. 3502; No Surprises Act, H.R. 3630; Lower Health Care Costs Act, S.1895; COVID-19 regulatory changes in general; Coronavirus Preparedness and Response Supplemental Appropriations (CPRSA) Act, the Families First Coronavirus Response Act (FFCRA), and the Coronavirus Aid, Relief, and Economic Security (CARES) Act - issues impacting GI patients, physicians and ambulatory surgery centers.
Showing 8 of 20 unique descriptions from filings.
Related Analysis
Related Investigations
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.